申请人:Catabasis Pharmaceuticals, Inc.
公开号:US20170073305A1
公开(公告)日:2017-03-16
The invention relates to fatty acid amides; compositions comprising an effective amount of a fatty acid amide; and methods for treating or preventing cancer, a metabolic disease or a neurodegenerative disease comprising the administration of an effective amount of a fatty acid amide.